• SENSEX 76,024.51
    -1,390.41 (--1.80%)
  • BANKNIFTY 50,827.50
    -737.35 (--1.43%)
  • Vodafone Idea
    8.57 19.15(%)
  • Hind.Aeronautics
    4,492.80 5,675.00(%)
  • HBL Engineering
    532.15 738.65(%)
  • Reliance Industr
    1,250.00 1,156.00(%)
  • HDFC Bank
    1,765.00 1,430.15(%)
  • Galaxy Surfact.
    2,096.20 3,366.30(%)
  • Adani Green
    916.95 758.00(%)
  • ICICI Bank
    1,315.00 1,048.35(%)
  • Zomato Ltd
    205.00 304.50(%)
  • Larsen & Toubro
    3,430.60 3,141.30(%)
  • Infosys
    1,518.00 1,359.10(%)
  • Bajaj Finance
    8,672.00 6,376.55(%)
  • Dixon Technolog.
    12,880.05 7,100.05(%)
  • IndusInd Bank
    689.85 1,576.00(%)
  • ITC
    405.50 381.24(%)
  • Nip. India Gold
    77.05 77.05(%)
  • St Bk of India
    763.05 679.65(%)
  • M & M
    2,625.00 1,891.30(%)
  • Trent
    5,619.85 8,345.85(%)
  • PB Fintech.
    1,505.90 1,110.25(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Vivo Bio Tech Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 3920.0
  • ISIN : INE380K01017
35.15 1 (3.47%)
  • As on 02 Apr 2025 (EOD)
  • Today’s Low

    33.57
  • Today’s High

    35.90
  • Open

    33.60
  • Perv Close

    33.97
  • 52W Low

    31.20
  • 52W High

    56.90

Key Indicators

  • P/E(TTM)

    8.37

  • Mar.Cap (₹Cr.)

    59.29

  • Div & Yield %

    0.00

  • Book Value(₹)

    38.20

  • Debt-Equity Ratio

    3.47

  • AGM Date

    01-Apr-2025

  • EPS

    4.20

  • P/E Ratio

    8.37

Financials Ratios

  • Debt-Equity Ratio

    1.27

  • Mar.Cap (₹Cr.)

    59.29

  • RONW (%)

    4.76

  • ROCE (%)

    9.88

Score Board

  • Equity (₹ in Cr.)

    16.87

  • BV (₹)

    38.20

  • Sales( ₹ in Cr.)

    44.88

  • NP (in Cr.)

    2.52

  • NP Var(%)

    -4.0

  • Div%

    0.0

  • CPS (₹)

    7.00

  • EPS (₹)

    1.50

  • Traded Value (₹ in Lakhs)

    59.29

  • 52 Week High

    56.90

  • 52 Week Low

    31.20

  • Price BSE

    35.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    59.29

  • P/C Ratio

    5.00

  • P/E Ratio

    23.40

  • Price Vs.BV

    1.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 44.88 51.62 51.39 51.78 55.35 55.83
Excise Duty 44.88 51.62 51.39 51.78 55.35 55.83
Net Sales 44.88 51.62 51.39 51.78 55.35 55.83
Other Income 0.04 0.04 0.09 0.08 0.05 0.01
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 44.92 51.66 51.48 51.85 55.41 55.85
EXPENDITURE :
Raw Materials 44.88 51.62 51.39 51.78 55.35 55.83
Power & Fuel Cost 44.88 51.62 51.39 51.78 55.35 55.83
Employee Cost 10.13 13.15 9.42 8.57 10.00 9.58
Other Manufacturing Expenses 0.19 0.33 0.37 0.12 8.21 6.73
Selling & Administrative Expenses 4.38 3.73 8.34 11.58 7.41 10.42
Miscellaneous Expenses 0.19 0.33 0.37 0.12 8.21 6.73
Less : Pre-operative Expenses Capitalised :
Total Expenditure 40.86 47.05 47.01 43.23 51.15 54.02
Operating Profit 5.24 6.16 6.00 6.63 8.71 7.84
Interest 7.78 7.65 3.99 3.53 3.10 2.64
Gross Profit 4.05 4.61 4.47 8.62 4.26 1.83
Depreciation 9.29 9.27 7.44 5.59 5.17 5.06
Profit Before Tax 4.05 4.61 4.47 8.62 4.26 1.83
Tax 1.68 1.03 0.76 1.36 1.12 0.38
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.14 0.94 1.51 1.58 -1.31 -0.80
Reported Net Profit 2.52 2.63 2.20 5.68 4.44 2.25
Extraordinary Items 4.05 4.61 4.47 8.62 4.26 1.83
Adjusted Net Profit 2.52 2.63 2.20 5.68 4.44 2.25
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 2.52 2.63 2.20 5.68 4.44 2.25
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.69 1.77 1.56 4.24 3.45 2.17
Book Value 0.00 0.00 0.00 0.00 0.00 0.00
Book Value(Adj)-Unit Curr 0.00 0.00 0.00 0.00 0.00 0.00

Shareholding Pattern

  • Promoter Group

    41.57%

  • Public Share Holding

    58.43%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 5,812,000 34.45 5,812,000 6
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,199,500 7.11 459,500 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 7,011,500 41.57 6,271,500 11
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 1,888,882 11.20 1,881,022 37
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 455,711 2.70 455,711 85
Foreign Non Institution Other 1,861,909 11.04 561,909 2
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,186,259 12.96 2,111,259 27
Individuals holding nominal share capital up to Rs. 1 lakh 3,464,159 20.54 3,233,132 21,006
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 100 0.00 100 1
Sub Total 9,857,020 58.43 8,243,133 21,158
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 16,868,520 100.00 14,514,633 21,169

Company Background

Vivo Bio Tech LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Vivo Bio Tech Ltd
  • BSE Code : 3920.0
  • ISIN : INE380K01017
  • Incorporation Year

    1987

  • Registered Office

    Survey #349/A Pregnapur Vlge
    , Gajel,
    Telangana-502311

  • Telephone

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    A V Kiran

  • Auditor

    P Murali & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Aarthi Consultants Pvt Ltd
    1-2-285,
    Domalguda,J B Apartments
    Mumbai - Hyderabad - 500 029

Vivo Bio Tech Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Vivo Bio Tech 35.15 44.92 44.88 8.37 10.06
Abbott India 30,305.85 6,097.18 5,848.91 48.26 44.71
Astrazeneca Phar 8,518.55 1,330.33 1,295.53 219.61 33.26
P & G Health Ltd 5,152.30 1,166.89 1,151.26 36.15 39.76
Glaxosmi. Pharma 2,793.40 3,530.73 3,407.25 55.55 44.44
Cipla 1,444.55 17,645.00 16,574.34 24.77 20.10
Amrutanjan Healt 642.85 437.58 421.23 37.68 20.84
Fermenta Biotec. 285.30 315.24 307.09 27.04 4.10
Guj. Themis Bio. 271.85 174.19 169.82 56.28 44.82
Bliss GVS Pharma 119.25 638.96 605.46 27.29 11.19
Ambalal Sarabhai 36.15 11.70 3.81 15.45 1.92